Canaccord Genuity Keeps Their Buy Rating on Intellia Therapeutics (NTLA)
at www.tipranks.com (Mon, 9-Nov 8:08 AM)
Wedbush Remains a Hold on Intellia Therapeutics (NTLA)
at www.tipranks.com (Mon, 9-Nov 5:45 AM)
Intellia Completes MAGNITUDE-2 Phase 3 Enrollment for One-Time ATTRv-PN Gene Editing Candidate Nex-z
Market Chameleon (Wed, 4-Nov 8:31 AM)
Market Chameleon (Tue, 13-Oct 11:26 AM)
Intellia uses inducement RSUs to add eight new hires under Nasdaq Rule 5635(c)(4)
Market Chameleon (Mon, 5-Oct 7:31 AM)
